Suppr超能文献

厄瓜多尔不同三杂交群体中该基因的遗传变异及其与祖先比例的关系。

Genetic Variations of the Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations.

作者信息

Farinango Camila, Gallardo-Cóndor Jennifer, Freire-Paspuel Byron, Flores-Espinoza Rodrigo, Jaramillo-Koupermann Gabriela, López-Cortés Andrés, Burgos Germán, Tejera Eduardo, Cabrera-Andrade Alejandro

机构信息

Facultad de Ingeniería y Ciencias Aplicadas, Universidad de Las Américas, Quito 170125, Ecuador.

Laboratorios de Investigación, Universidad de Las Américas, Quito 170125, Ecuador.

出版信息

J Pers Med. 2022 Jun 10;12(6):950. doi: 10.3390/jpm12060950.

Abstract

Dihydropyrimidine dehydrogenase is one of the main pharmacological metabolizers of fluoropyrimidines, a group of drugs widely used in clinical oncology. Around 20 to 30% of patients treated with fluoropyrimidines experience severe toxicity caused by a partial or total decrease in enzymatic activity. This decrease is due to molecular variants in the DPYD gene. Their prevalence and allelic frequencies vary considerably worldwide, so their description in heterogeneous groups such as the Ecuadorian population will allow for the description of pharmacogenetic variants and proper characterization of this population. Thus, we genotyped all the molecular variants with a predictive value for DPYD in a total of 410 Ecuadorian individuals belonging to Mestizo, Afro-Ecuadorian, and Indigenous ethnic groups. Moreover, we developed a genetic ancestry analysis using 46 autosomal ancestry informative markers. We determined 20 genetic variations in 5 amplified regions, including 3 novel single nucleotide variants. The allele frequencies for DPYD variants c.1627G>A (*5, rs1801159), c.1129-15T>C (rs56293913), c.1218G>A (rs61622928), rs1337752, rs141050810, rs2786783, rs2811178, and g.97450142G>A (chr1, GRCh38.p13) are significantly related to Native American and African ancestry proportions. In addition, the FST calculated from these variants demonstrates the closeness between Indigenous and Mestizo populations, and evidences genetic divergence between Afro-Ecuadorian groups when compared with Mestizo and Indigenous ethnic groups. In conclusion, the genetic variability in the DPYD gene is related to the genetic component of ancestral populations in different Ecuadorian ethnic groups. The absence and low frequency of variants with predictive value for fluoropyrimidine toxicity such as DPYD *2A, HapB3, and c.2846A>T (prevalent in populations with European ancestry) is consistent with the genetic background found.

摘要

二氢嘧啶脱氢酶是氟嘧啶类药物的主要药理代谢酶之一,氟嘧啶类药物是临床肿瘤学中广泛使用的一类药物。接受氟嘧啶类药物治疗的患者中,约20%至30%会因酶活性部分或完全降低而出现严重毒性。这种降低是由于DPYD基因的分子变异所致。其在全球范围内的患病率和等位基因频率差异很大,因此在厄瓜多尔人群等异质群体中对其进行描述,将有助于描述药物遗传学变异并对该人群进行恰当表征。因此,我们对总共410名属于梅斯蒂索人、非裔厄瓜多尔人和印第安人族群的厄瓜多尔个体中所有对DPYD具有预测价值的分子变异进行了基因分型。此外,我们使用46个常染色体祖先信息标记进行了遗传血统分析。我们在5个扩增区域确定了20个遗传变异,包括3个新的单核苷酸变异。DPYD变异体c.1627G>A(*5,rs1801159)、c.1129-15T>C(rs56293913)、c.1218G>A(rs61622928)、rs1337752、rs141050810、rs2786783、rs2811178和g.97450142G>A(chr1,GRCh38.p13)的等位基因频率与美洲原住民和非洲血统比例显著相关。此外,根据这些变异体计算出的FST表明印第安人和梅斯蒂索人群体之间的亲缘关系,并证明非裔厄瓜多尔人群体与梅斯蒂索人和印第安人族群相比存在遗传差异。总之,DPYD基因的遗传变异性与不同厄瓜多尔族群祖先群体的遗传成分有关。对于氟嘧啶毒性具有预测价值的变异体如DPYD *2A、HapB3和c.2846A>T(在欧洲血统人群中普遍存在)的缺失和低频与所发现的遗传背景一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1963/9225136/d80417f964e6/jpm-12-00950-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验